Monday, 28 September 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Mangalam Drugs and Organics Ltd

NSE: MANGALAM · BSE: 532637 · Pharmaceuticals & Biotechnology · 9 announcements

Share price: ₹31.83
Market cap: ₹50.38 Cr
Revenue (annual): ₹232.1 Cr
Net profit (annual): ₹-44.40 Cr
P/E (TTM): -1.3×Sector 50.4×
Promoter holding: 35.65%+0.00% QoQ
FII holding: 0.11%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 2 Financial Results 2 Other Announcement 1 Legal & Regulatory 1 Debt & Borrowing 1 Board Meeting Outcome 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

12 Aug 2026 17:17 IST BSE

Financial Results

Mangalam Drugs and Organics Q1 FY27 Results: Net Loss of ₹7.6 Cr, Loss Narrows

Mangalam Drugs and Organics Ltd reported revenue from operations of ₹57.1 Cr (-0.2% YoY) and a net loss of ₹7.6 Cr for Q1 FY27.

Key figure: Net loss ₹7.6 Cr

Open full results → Read the filing ↗

14 May 2026 17:46 IST BSE

Financial Results

Mangalam Drugs and Organics Q4 FY26 Results: Net Loss of ₹13.4 Cr

Mangalam Drugs and Organics Ltd reported revenue from operations of ₹67.3 Cr (-7.6% YoY) and a net loss of ₹13.4 Cr for Q4 FY26.

Key figure: Net loss ₹13.4 Cr

Open full results → Read the filing ↗